JP2017526619A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526619A5 JP2017526619A5 JP2016572424A JP2016572424A JP2017526619A5 JP 2017526619 A5 JP2017526619 A5 JP 2017526619A5 JP 2016572424 A JP2016572424 A JP 2016572424A JP 2016572424 A JP2016572424 A JP 2016572424A JP 2017526619 A5 JP2017526619 A5 JP 2017526619A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- cells
- stem cells
- use according
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014902194A AU2014902194A0 (en) | 2014-06-10 | Treatment of immune disorders | |
| AUAU2014902194 | 2014-06-10 | ||
| AUAU2014902257 | 2014-06-13 | ||
| AU2014902257A AU2014902257A0 (en) | 2014-06-13 | Treatment of immune disorders 2 | |
| PCT/EP2015/062138 WO2015189063A1 (en) | 2014-06-10 | 2015-06-01 | Treatment of immune disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020195123A Division JP7009594B2 (ja) | 2014-06-10 | 2020-11-25 | 免疫疾患の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526619A JP2017526619A (ja) | 2017-09-14 |
| JP2017526619A5 true JP2017526619A5 (enExample) | 2018-07-12 |
| JP6800757B2 JP6800757B2 (ja) | 2020-12-16 |
Family
ID=53385603
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572424A Active JP6800757B2 (ja) | 2014-06-10 | 2015-06-01 | 免疫疾患の治療 |
| JP2020195123A Active JP7009594B2 (ja) | 2014-06-10 | 2020-11-25 | 免疫疾患の治療 |
| JP2022003013A Active JP7279212B2 (ja) | 2014-06-10 | 2022-01-12 | 免疫疾患の治療 |
| JP2023077363A Active JP7680493B2 (ja) | 2014-06-10 | 2023-05-09 | 免疫疾患の治療 |
| JP2025078086A Pending JP2025109787A (ja) | 2014-06-10 | 2025-05-08 | 免疫疾患の治療 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020195123A Active JP7009594B2 (ja) | 2014-06-10 | 2020-11-25 | 免疫疾患の治療 |
| JP2022003013A Active JP7279212B2 (ja) | 2014-06-10 | 2022-01-12 | 免疫疾患の治療 |
| JP2023077363A Active JP7680493B2 (ja) | 2014-06-10 | 2023-05-09 | 免疫疾患の治療 |
| JP2025078086A Pending JP2025109787A (ja) | 2014-06-10 | 2025-05-08 | 免疫疾患の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US10624930B2 (enExample) |
| EP (2) | EP4137146A1 (enExample) |
| JP (5) | JP6800757B2 (enExample) |
| KR (4) | KR102704978B1 (enExample) |
| CN (2) | CN114129598A (enExample) |
| AU (2) | AU2015273799B2 (enExample) |
| CA (1) | CA2950804C (enExample) |
| SG (1) | SG11201609993YA (enExample) |
| WO (1) | WO2015189063A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012048093A2 (en) | 2010-10-08 | 2012-04-12 | Osiris Therapeutics, Inc. | Enhanced msc preparations |
| EP2714057B1 (en) * | 2011-06-03 | 2019-11-06 | Mesoblast, Inc. | Methods of treating or preventing neurological diseases |
| PL2785359T3 (pl) | 2011-11-30 | 2018-12-31 | Astellas Institute For Regenerative Medicine | Mezenchymalne komórki zrębowe i związane z nimi zastosowania |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| CN104471059B (zh) | 2012-07-12 | 2018-04-17 | 珠海横琴爱姆斯坦生物科技有限公司 | 人胚胎干细胞衍生的间充质样干细胞、方法及其应用 |
| WO2015189063A1 (en) | 2014-06-10 | 2015-12-17 | Mesoblast International Sàrl | Treatment of immune disorders |
| CN106929474B (zh) * | 2017-03-31 | 2021-09-14 | 北京恒峰铭成生物科技有限公司 | 一种m2巨噬细胞诱导剂 |
| AU2018243554C1 (en) * | 2017-03-31 | 2025-01-30 | Wisconsin Alumni Research Foundation | Generation of therapeutic cells using extracellular components of target organs |
| EP3716988A4 (en) | 2017-11-29 | 2021-12-15 | Figene, LLC | INTERACTION OF FIBROBLASTS AND IMMUNE CELLS FOR THE ACTIVATION AND USE THEREOF |
| WO2021176001A1 (en) | 2020-03-05 | 2021-09-10 | Mesoblast International Sàrl | Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells |
| CN112007165B (zh) * | 2020-08-27 | 2021-10-08 | 北京大学人民医院 | 巨噬细胞极化调节剂及其在促进血小板生成中的应用 |
| EP4630018A1 (en) * | 2022-12-09 | 2025-10-15 | Mesoblast International Sàrl | Method of treating inflammation with cellular compositions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| AU2003901668A0 (en) | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| CA2564679C (en) * | 2004-03-22 | 2015-06-23 | Osiris Therapeutics, Inc. | Mesenchymal stem cells and uses therefor |
| CN101103101B (zh) * | 2004-09-24 | 2012-10-10 | 成血管细胞系统公司 | 增强间充质前体细胞（mpc）的增生和/或存活的方法 |
| US8367405B2 (en) | 2005-04-12 | 2013-02-05 | Mesoblast, Inc. | Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| WO2010005527A1 (en) * | 2008-06-30 | 2010-01-14 | Angioblast Systems, Inc. | Treatment of eye diseases and excessive neovascularization using a combined therapy |
| WO2010059828A1 (en) * | 2008-11-19 | 2010-05-27 | Anthrogenesis Corporation | Amnion derived adherent cells |
| JP5678360B2 (ja) * | 2009-09-28 | 2015-03-04 | 株式会社ジーシー | 間葉系幹細胞の培養方法 |
| US20140017787A1 (en) * | 2010-10-11 | 2014-01-16 | Aline M. Betancourt | Mesenchymal stem cells and related therapies |
| PL2785359T3 (pl) * | 2011-11-30 | 2018-12-31 | Astellas Institute For Regenerative Medicine | Mezenchymalne komórki zrębowe i związane z nimi zastosowania |
| CN102899293A (zh) | 2012-11-01 | 2013-01-30 | 上海市肺科医院 | 促血管生成素1基因修饰的间充质干细胞、及其构建方法与应用 |
| KR102577698B1 (ko) * | 2014-04-07 | 2023-09-12 | 메조블라스트 인터내셔널 에스에이알엘 | 개선된 줄기 세포 조성물 |
| WO2015189063A1 (en) * | 2014-06-10 | 2015-12-17 | Mesoblast International Sàrl | Treatment of immune disorders |
-
2015
- 2015-06-01 WO PCT/EP2015/062138 patent/WO2015189063A1/en not_active Ceased
- 2015-06-01 EP EP22187393.8A patent/EP4137146A1/en active Pending
- 2015-06-01 KR KR1020237007387A patent/KR102704978B1/ko active Active
- 2015-06-01 CA CA2950804A patent/CA2950804C/en active Active
- 2015-06-01 EP EP15728457.1A patent/EP3154565B1/en active Active
- 2015-06-01 SG SG11201609993YA patent/SG11201609993YA/en unknown
- 2015-06-01 AU AU2015273799A patent/AU2015273799B2/en active Active
- 2015-06-01 KR KR1020257031878A patent/KR20250143870A/ko active Pending
- 2015-06-01 CN CN202111351585.8A patent/CN114129598A/zh active Pending
- 2015-06-01 US US15/317,673 patent/US10624930B2/en active Active
- 2015-06-01 CN CN201580030754.4A patent/CN106659743B/zh active Active
- 2015-06-01 JP JP2016572424A patent/JP6800757B2/ja active Active
- 2015-06-01 KR KR1020247029823A patent/KR102865313B1/ko active Active
- 2015-06-01 KR KR1020177000032A patent/KR20170007854A/ko not_active Ceased
-
2020
- 2020-03-24 US US16/828,121 patent/US11406669B2/en active Active
- 2020-09-28 AU AU2020244403A patent/AU2020244403B2/en active Active
- 2020-11-25 JP JP2020195123A patent/JP7009594B2/ja active Active
-
2022
- 2022-01-12 JP JP2022003013A patent/JP7279212B2/ja active Active
- 2022-07-22 US US17/870,936 patent/US12257270B2/en active Active
-
2023
- 2023-05-09 JP JP2023077363A patent/JP7680493B2/ja active Active
-
2025
- 2025-01-17 US US19/030,861 patent/US12616722B2/en active Active
- 2025-05-08 JP JP2025078086A patent/JP2025109787A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Donate-Correa et al. | Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications | |
| Jiang et al. | Ischemic stroke: From pathological mechanisms to neuroprotective strategies | |
| Xiao et al. | S100 proteins in atherosclerosis | |
| Tan et al. | Curcumin relieved cisplatin-induced kidney inflammation through inhibiting Mincle-maintained M1 macrophage phenotype | |
| Ding et al. | β‐Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria | |
| Chen et al. | Mitochondrial transfer as a therapeutic strategy against ischemic stroke | |
| KR102275822B1 (ko) | 분리된 미토콘드리아를 포함하는 류마티스 관절염 예방 또는 치료용 약학 조성물 | |
| JP2018505158A5 (enExample) | ||
| Yang et al. | Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy | |
| Eide et al. | Implications of age-related changes in the blood-brain barrier for ischemic stroke and new treatment strategies | |
| Kang et al. | The role of visfatin in diabetic nephropathy | |
| JP2017508455A5 (enExample) | ||
| JP2011509257A5 (enExample) | ||
| CN109453367A (zh) | 成纤维细胞生长因子21在急性肝损伤回肠粘膜损伤中的应用 | |
| JP2011246454A (ja) | 安全な免疫抑制剤または免疫異常抑制剤組成物 | |
| CN109908165B (zh) | 一种含有雷公藤红素的组合物及其应用 | |
| CN102579510A (zh) | 冬虫夏草的一种新用途 | |
| JP5947041B2 (ja) | 安全なｉｌ−１７産生抑制剤 | |
| Li et al. | Alleviative effect of dihydroquercetin on chronic heart failure in rats and its impact on inflammatory response, oxidative stress and cardiac myocyte apoptosis | |
| Tanji et al. | DPP-4 inhibition ameliorates pancreatic β-cell failure and improves glucose tolerance in the mouse model of Wolfram syndrome | |
| Olsson et al. | Preserved leukocyte CD11b expression at the site of interstitial inflammation in patients with high-flux hemodiafiltration | |
| CN112386696A (zh) | 一种治疗胰岛素抵抗的靶点及其应用 | |
| CN105078943B (zh) | 虾青素在制备子痫前期预防或治疗产品中的应用 | |
| CN109999044A (zh) | 一种含有醉茄素a的组合物及其应用 | |
| Liu et al. | Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study |